Vimarsana
Biggest News Aggregation in the World

Page 6 - Altavant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altavant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altavant Sciences Today - Breaking & Trending Today

Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021 - Vimarsana News

Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...

Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021 - Vimarsana News

Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...

Urovant Sciences, Inc.: Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA (vibegron) 75 mg for Overactive Bladder at the 2021 Annual Meeting of the American Urological Association - Vimarsana News

Urovant Sciences, Inc.: Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA (vibegron) 75 mg for Overactive Bladder at the 2021 Annual Meeting of the American Urological Association

Data from the dedicated, stand-alone, ambulatory blood pressure trial will be the focus of a podium presentation Efficacy in patients with 'dry' overactive bladder, based on a post-hoc analysis

Urovant Sciences Appoints Betzy Estrada as Executive Vice President and Chief Human Resources Officer - Vimarsana News

Urovant Sciences Appoints Betzy Estrada as Executive Vice President and Chief Human Resources Officer

Urovant Sciences, Inc., a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced the appointment of Betzy Estrada as executive vice president and chief human resources officer. In her

Sumitovant Biopharma Has a Strong Fourth Quarter with Significant Clinical Development and Corporate Achievements Across its Portfolio of Companies - Vimarsana News

Sumitovant Biopharma Has a Strong Fourth Quarter with Significant Clinical Development and Corporate Achievements Across its Portfolio of Companies

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly owned subsidiary companies (Urovant, Enzyvant, Altavant and...